1302573 - Oncomed Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - OMED (1302573)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
52 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S10+3-27-41+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-10-10
OMEDStagg RobertSVP, Clinical R, DS - Sale$2.01-92740,670-2%-$1,863
2018-10-10
OMEDLi YvonneSee RemarksS - Sale$2.02-92759,734-2%-$1,873
2018-10-10
OMEDGurney AustinSee RemarksS - Sale$2.01-1,15677,924-1%-$2,324
2018-10-10
OMEDHager Alicia J.SVP, GCS - Sale$2.02-1,15651,754-2%-$2,335
2018-10-10
OMEDLewicki John A.Pres, CEOS - Sale$2.01-1,156155,354-1%-$2,324
2018-10-09
OMEDLi YvonneSee RemarksS - Sale$2.13-1,22960,661-2%-$2,616
2018-10-09
OMEDGurney AustinSee RemarksS - Sale$2.13-1,68679,080-2%-$3,589
2018-10-09
OMEDStagg RobertSVP, Clinical R, DS - Sale$2.13-1,68641,597-4%-$3,589
2018-10-09
OMEDLewicki John A.Pres, CEOS - Sale$2.13-2,296156,510-1%-$4,888
2018-10-09
OMEDHager Alicia J.SVP, GCS - Sale$2.13-1,68652,910-3%-$3,589
2018-04-24
OMEDLi YvonneSee RemarksS - Sale$2.68-5,06259,890-8%-$13,555
2018-04-24
OMEDStagg RobertSVP, Clinical R, DS - Sale$2.68-4,05143,283-9%-$10,848
2018-04-24
OMEDLewicki John A.Pres, CEOS - Sale$2.68-4,557154,806-3%-$12,202
2018-04-24
OMEDGurney AustinSee RemarksS - Sale$2.68-4,05176,766-5%-$10,848
2018-04-24
OMEDHager Alicia J.SVP, GCS - Sale$2.68-4,05154,596-7%-$10,848
D
2018-02-26
OMEDKarsen Perry ADirA - Grant$0.00+70,50080,500+705%+$0
2017-10-10
OMEDPatel SunilSee RemarksS - Sale$4.24-1,24868,336-2%-$5,295
2017-10-10
OMEDHastings Paul JCOB, CEOS - Sale$4.24-1,398401,0280%-$5,931
2017-10-10
OMEDLewicki John A.EVP, Research, DevelopmentS - Sale$4.24-1,248159,363-1%-$5,295
2017-10-10
OMEDGurney AustinSee RemarksS - Sale$4.24-1,24880,817-2%-$5,295
2017-10-10
OMEDHager Alicia J.SVP, GCS - Sale$4.24-1,24858,647-2%-$5,295
D
2017-10-07
OMEDPatel SunilSee RemarksA - Grant$0.00+25,00069,584+56%+$0
D
2017-10-07
OMEDLewicki John A.EVP, Research, DevelopmentA - Grant$0.00+25,000160,611+18%+$0
D
2017-10-07
OMEDHager Alicia J.SVP, GCA - Grant$0.00+18,33459,895+44%+$0
D
2017-10-07
OMEDGurney AustinSee RemarksA - Grant$0.00+18,33482,065+29%+$0
2017-06-05
OMEDKarsen Perry ADirP - Purchase$3.46+10,00010,000New+$34,588
2017-05-25
OMEDLasersohn Jack WDirP - Purchase$3.37+34,6141,685,913+2%+$116,639
M
2017-05-24
OMEDRoot Jonathan DDirS - Sale$3.71-13,880121,020-10%-$51,441
2017-05-23
OMEDLasersohn Jack WDirP - Purchase$3.55+20,0001,651,299+1%+$71,000
2017-05-19
OMEDRoot Jonathan DDirS - Sale$3.70-7,487134,900-5%-$27,712
2017-05-16
OMEDLasersohn Jack WDirP - Purchase$3.49+23,5071,631,299+1%+$82,061
2017-05-16
OMEDRoot Jonathan DDirS - Sale$3.58-6,900142,387-5%-$24,714
D
2017-04-23
OMEDHoey TimothySVP, Cancer Biology, Co-CSOA - Grant$0.00+20,00077,225+35%+$0+70
D
2017-04-23
OMEDPatel SunilSee RemarksA - Grant$0.00+20,00044,584+81%+$0+70
D
2017-04-24
OMEDHastings Paul JCOB, CEOA - Grant$0.00+45,000402,426+13%+$0+70
D
2017-04-23
OMEDLewicki John A.EVP, Research, DevelopmentA - Grant$0.00+22,500134,388+20%+$0+70
D
2017-04-23
OMEDGurney AustinSee RemarksA - Grant$0.00+20,00063,301+46%+$0+70
D
2017-04-23
OMEDHager Alicia J.SVP, GCA - Grant$0.00+20,00041,561+93%+$0+70
2017-04-04
OMEDLewicki John A.EVP, Research, DevelopmentS - Sale$9.06-5,754111,888-5%-$52,113+3-41-56
2017-04-04
OMEDGurney AustinSee RemarksS - Sale$9.06-5,75443,301-12%-$52,113+3-41-56
2017-04-04
OMEDPatel SunilSee RemarksS - Sale$9.06-5,75424,584-19%-$52,113+3-41-56
2017-04-04
OMEDHoey TimothySVP, Cancer Biology, Co-CSOS - Sale$9.06-5,75457,225-9%-$52,113+3-41-56
2017-04-04
OMEDHager Alicia J.SVP, GCS - Sale$9.06-4,31621,561-17%-$39,089+3-41-56
2017-04-04
OMEDHastings Paul JCOB, CEOS - Sale$9.06-6,473357,426-2%-$58,625+3-41-56
D
2017-03-15
OMEDHager Alicia J.SVP, GCS - Sale+OE$10.00-6,65225,877-20%-$66,520-3-8-59
D
2017-03-15
OMEDHager Alicia J.SVP, GCM - OptEx$3.42+6,65225,877+35%+$22,750-3-8-59
DM
2017-01-05
OMEDHastings Paul JCOB, CEOS - Sale+OE$8.34-42,738362,163-11%-$356,559+1-8-9
DM
2017-01-05
OMEDHastings Paul JCOB, CEOM - OptEx$1.43+42,738362,163+13%+$61,115+1-8-9
D
2017-01-03
OMEDLewicki John A.EVP, Research, DevelopmentS - Sale+OE$7.63-9,175116,451-7%-$70,045+5-2-1
D
2017-01-03
OMEDLewicki John A.EVP, Research, DevelopmentM - OptEx$1.43+9,175116,451+9%+$13,120+5-2-1
D
2017-01-03
OMEDHoey TimothySVP, Cancer Biology, Co-CSOS - Sale+OE$7.64-12,76360,979-17%-$97,448+5-2-1
D
2017-01-03
OMEDHoey TimothySVP, Cancer Biology, Co-CSOM - OptEx$1.43+12,76360,979+26%+$18,251+5-2-1
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top